Merck

Synthesia has raised $200 million in a Series E round, doubling its valuation to $4 billion and surpassing $100 million…

A personalized mRNA vaccine combined with standard immunotherapy nearly halved the risk of recurrence or death in high-risk melanoma patients…

Biotech cybersecurity risks go beyond data breaches, threatening research, manufacturing, and biological safety, with potential irreversible consequences like disrupted scientific…